Paid Clinical Trials in Melrose Park, IL
As of August 2026, 15 paid clinical trials are recruiting in Melrose Park, Illinois. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Melrose Park offers studies at sites including Marjorie Weinberg Cancer Center at Loyola-Gottlieb for conditions such as Anaplastic Large Cell Lymphoma, ALK-Negative, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
0 clinical trials
·Clear filters·Top Research Study Locations in Melrose Park
Researchers run research studies in Melrose Park, IL at 2 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Marjorie Weinberg Cancer Center at Loyola-Gottlieb | Anaplastic Large Cell Lymphoma, ALK-Negative, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 8 |
| DM Clinical Research - Chicago | Clostridoides Difficile Associated Disease, Healthy Volunteers, Human Metapneumovirus Immunization | 2 |
Active & Upcoming Studies in Melrose Park (2026)
Recruiting trials in Melrose Park grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (8 active studies)
- Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy · Phase 3 · Alliance for Clinical Trials in Oncology
- Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy · Phase 3 · Eastern Cooperative Oncology Group
Diabetes & metabolic (3 active studies)
- A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight · Phase 3 · AstraZeneca
- A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
Vaccines (1 active study)
Common conditions studied in Melrose Park
- Anaplastic Large Cell Lymphoma, ALK-Negative (1 active study)
- Anatomic Stage I Breast Cancer AJCC v8 (1 active study)
- Anatomic Stage II Breast Cancer AJCC v8 (1 active study)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (1 active study)
- Anatomic Stage IIIB Breast Cancer AJCC v8 (1 active study)
- Anatomic Stage IV Breast Cancer AJCC v8 (1 active study)
Leading research sponsors in Melrose Park
- AstraZeneca
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- Eastern Cooperative Oncology Group
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Melrose Park?
There are approximately 15 recruiting clinical trials in Melrose Park, Illinois listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Melrose Park pay participants?
Most recruiting trials in Melrose Park compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Melrose Park?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Melrose Park?
The most common conditions under active study in Melrose Park include Anaplastic Large Cell Lymphoma, ALK-Negative (1), Anatomic Stage I Breast Cancer AJCC v8 (1), Anatomic Stage II Breast Cancer AJCC v8 (1), Anatomic Stage IIIA Breast Cancer AJCC v8 (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Melrose Park?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Melrose Park on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Melrose Park?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Melrose Park?
Recruiting research sites in Melrose Park include Marjorie Weinberg Cancer Center at Loyola-Gottlieb, DM Clinical Research - Chicago, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Melrose Park right now?
The largest active categories in Melrose Park are Cancer & tumors (8), Diabetes & metabolic (3), Vaccines (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.